The Effect of Using Nebula Bear on Anxiety and Fear During Nebulizer Application in Children
1 other identifier
interventional
40
1 country
1
Brief Summary
Many respiratory system diseases are treated with inhalers. Providing inhaler treatment is provided by nebulizer devices. Taking the exact and effective dose of inhaler treatment affects the patient's recovery process. The use of nebulizer devices in children differs from that in adults. For children, the nebulizer may seem foreign and scary, which may cause them to reject inhaler treatment. Therefore, it is important to reduce anxiety and fear in children during nebulizer treatment. Since it is thought that the nebulizer bear, which is planned to be used in the study to reduce these negative situations caused by nebulizer treatment, may be effective in reducing anxiety and fear in children, it is thought that the study will have a positive physical and psychological contribution to children and parents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 28, 2024
CompletedFirst Submitted
Initial submission to the registry
December 31, 2024
CompletedFirst Posted
Study publicly available on registry
January 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedJanuary 10, 2025
December 1, 2024
3 months
December 31, 2024
January 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Parent and Child Information Form
Parent and child information form was created by researchers according to the literature. In the form content; It contains information about introductory characteristics about the child and the family (age, mother's education level, number of children, medical diagnosis, previous hospitalization, previous use of nebule therapy) and consists of 9 questions.
It will be filled out by the parent within the first 60 minutes of the child's hospitalization. (Approximately 5 minute.)
Child Fear Scale
This scale was used by McMurty et al.ild or the researcher to measure children's anxiety levels. It was developed by in 2011. The scale was developed by Gerçeker et al. in 2018. It has been validated in Turkish by and is aimed at children aged 4-10. Facial muscles changes in fearful expressions were drawn by a graphic designer based on photographs of frigtened faces. The scale can be used by the family, the child or the researcher to evaluate children. In this scale, the child is shown a scale containing five facial expressions rated between 0 and 4 points. While 0 indicates no fear and anxiety; 4 shows the highest fear and anxiety. These are: "0" neutral expression (no anxiety), "1" very little fear (very little anxiety), "2" some fear (some anxiety), "3" more fear (more anxiety), "4" the most fear possible. It is considered high fear (severe anxiety).
It will be filled out by the researcher and parent 5 minutes before the procedure and 5 minutes after the procedure (Approximately 10 minute).
Children's Anxiety Meter-State (CAM-S)
Children's Anxiety Meter-State was developed by Ersig et al. in 2013. A scale is a scale similar to a thermometer with horizontal lines. It is aimed at children aged 4-10 and was developed to measure children's anxiety. Teach kids: "Imagine all your anxious feelings are at the bottom." When instructed" If anxious feelings are high, paint the thermometer upwards with a pencil.Before filling out the scale, the child's number ordering level should be evaluated. Children who do not understand these instructions are not allowed to fill out the scale. After the child makes a rating on the scale, a transparent meter is placed on the scale and the marked point is measured.Half-point increments are rounded to the nearest number. The scale score is between 0-10.
It will be filled out by the child 5 minutes before the procedure and 5 minutes after the procedure (Approximately 5 minute).
Study Arms (2)
Experimental: Nebula Bear Group
EXPERIMENTALActive Comparator: Control
ACTIVE COMPARATORInterventions
The children in this group and their mothers will be informed about the research and their written consent will be obtained. The scale will be filled in before the application. Before the application, Nebul will introduce the teddy bear to the mother and child. The teddy bear cannot be washed because it contains an electronic device. Therefore, it will be disinfected with a solution containing 60-70% alcohol before and after use. The recorded voice will then be played to the child and mother. Then, routine nebulizer treatment will be applied and the second audio recording will be played at the end of the treatment. The researcher will be with the child. At the end of the nebulizer treatment, after the mask is removed, the Child Fear Scale and the Child Anxiety Scale-State Scale will be filled out. The Child Fear Scale will be filled in by both the mother and the nurse and the average will be taken.
The children in this group and their parents will be informed about the research and their written consent will be obtained. Scales will be filled in before application. Children in this group will receive routine nebulizer treatment and routine application will be performed. At the end of the treatment, the scales will be filled in again.
Eligibility Criteria
You may qualify if:
- Are between the ages of 4-6, Parent's ability to read and write Turkish, Accompanied by their parents, Children who are willing to participate in the research will be included in the research, They receive the first nebule treatment of their hospitalization.
You may not qualify if:
- Have mental disabilities or communication problems, Visual or hearing impairment, Those who have any body function deficiency Children who routinely use nebulizers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Necmettin Erbakan University
Konya, Meram, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Master Student/Nurse
Study Record Dates
First Submitted
December 31, 2024
First Posted
January 10, 2025
Study Start
December 28, 2024
Primary Completion
March 30, 2025
Study Completion
June 30, 2025
Last Updated
January 10, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share